2.0
6 July 2026
Anonymous employee
Former employee, more than 1 year
Recommend
CEO approval
Business outlook
Pros
Excellent Medication, Strong Investment in Market Access, amazing launch
Cons
Poor leadership, increasing negative culture, reactive leaders, withholding of important information, inexperienced leaders, blame culture